UPIC Audits of Infusion and Injection Drug Claims

Since October 1, 2023, a Medicare claim for a drug supplied in a single-dose container that does not carry the correct JW or JZ modifier can be returned as unprocessable before a Unified Program Integrity Contractor ever opens a file. The modifiers tell CMS whether any part of the vial was discarded: JW reports a discarded amount, JZ attests that none was. A UPIC auditing infusion and injection claims checks more than whether the modifier is present: it checks whether the modifier matches the invoice, the administration record, and the units actually billed.

The JW and JZ Modifier Requirement

CMS has required the JW modifier on single-dose container drugs with a discarded amount since January 1, 2017. The JZ modifier, attesting that nothing was discarded, became mandatory no later than July 1, 2023. Both modifiers apply only to single-dose or single-use containers, not multi-dose vials, and the rule exists because CMS pays for the discarded amount as well as the dose administered, up to the labeled amount on the vial. A reviewer checks first for the modifier's presence, then for whether the quantity reported as discarded is consistent with the vial size actually purchased for that patient.

Matching Invoices to Billed Units

CMS does not prescribe a specific format for discarded-drug documentation, but it does expect providers to keep accurate purchasing and inventory records for every drug billed to Medicare. A UPIC reconstructs billed units from two independent sources, the purchase invoices for the drug and the administration record, and compares both against the units billed on the claim. A practice that buys single-dose vials in a size that does not evenly divide into its typical dose, and bills the full vial size as discarded on every claim, draws attention for looking automatic rather than patient-specific. The same documentation-to-claim matching that UPICs apply in UPIC Audits of DME Suppliers carries over here: the purchase record either supports the billed units or it does not.

A JW or JZ modifier is an attestation, not a formality. A UPIC that finds the invoice does not match the modifier treats every claim using that modifier the same way.

Administration Documentation UPICs Look For

Beyond the modifier, a UPIC infusion review reads the administration record itself: start and stop times, the dose actually given, who administered it, and, where required, a signature log confirming the clinician's identity when the signature in the record is illegible or missing. A chart that supports the diagnosis but not the specific units administered and discarded on that date is the gap a reviewer samples first. The requirement holds whether the drug was given in a physician's office, an infusion suite, or a hospital outpatient department: the record has to tie the billed units to what was actually administered that day, not to a standing order.

What a Modifier Mismatch Triggers

A single-claim denial does not have to stay single. Where CMS finds a sustained or high level of payment error, a UPIC can extrapolate a sample of flagged infusion claims across the full audit period, and a pattern across multiple patients or multiple dates can support a referral beyond a civil recoupment, including a target letter opening a criminal inquiry into the practice's billing. The modifier itself does not have to be the end of the exposure. The UPIC's real question is whether the pattern reflects routine, inflated discarded-drug claims across the practice, not a single documentation lapse.

Why Early Legal Counsel Is Critical

It is critical that practices promptly retain experienced healthcare defense counsel upon receiving a UPIC additional documentation request or a notice of modifier-related review. Early legal intervention can protect the practice's rights, help shape appropriate responses to the contractor's requests, avoid inadvertent admissions about how discarded amounts are calculated, preserve relevant defenses, and allow counsel to communicate with investigators on the practice's behalf. Delaying legal representation can significantly affect the outcome of a matter and expose the practice to unnecessary risk.

How Health Law Alliance Can Help

Health Law Alliance defends providers nationwide through UPIC drug-billing audits, from the first additional documentation request through any extrapolated recoupment.

Health Law Alliance's attorneys have overseen 2,000+ audits and handled 5,000+ matters, with 25+ years of experience.

If your practice has received a UPIC audit notice involving infusion or injection drug claims, contact us today for a free consultation through our UPIC audit defense practice.